GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (NYSE:WST) » Definitions » Cash Flow for Dividends

WST (West Pharmaceutical Services) Cash Flow for Dividends : $-59 Mil (TTM As of Sep. 2024)


View and export this data going back to 1980. Start your Free Trial

What is West Pharmaceutical Services Cash Flow for Dividends?

West Pharmaceutical Services's cash flow for dividends for the three months ended in Sep. 2024 was $-15 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was $-59 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

West Pharmaceutical Services's quarterly payment of dividends declined from Mar. 2024 ($-15 Mil) to Jun. 2024 ($-15 Mil) and declined from Jun. 2024 ($-15 Mil) to Sep. 2024 ($-15 Mil).

West Pharmaceutical Services's annual payment of dividends increased from Dec. 2021 ($-51 Mil) to Dec. 2022 ($-54 Mil) and increased from Dec. 2022 ($-54 Mil) to Dec. 2023 ($-57 Mil).

West Pharmaceutical Services Cash Flow for Dividends Historical Data

The historical data trend for West Pharmaceutical Services's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Cash Flow for Dividends Chart

West Pharmaceutical Services Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -45.10 -48.10 -51.10 -54.10 -57.00

West Pharmaceutical Services Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.00 -14.80 -14.70 -14.60 -14.50

West Pharmaceutical Services Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

West Pharmaceutical Services Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (NYSE:WST) » Definitions » Cash Flow for Dividends
Comparable Companies
COO HOLX BAX ALGN AVTR ATR RMD TFX RGEN MMSI ISRG XPAR:EL BDX TSE:7741 XSWX:ALC TSE:4543 OCSE:COLO B XSWX:STMN TSE:7733 XPAR:DIM
Traded in Other Exchanges
WST:Mexico WPS:Germany WPS:Germany W2ST34:Brazil
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-1147
Website
https://www.westpharma.com
West Pharmaceutical Services is based in Pennsylvania, us, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Executives
Charles Witherspoon officer: VP & Treasurer 530 HERMAN O WEST DRIVE, EXTON PA 19341
Eric Mark Green officer: Chief Executive Officer 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Silji Abraham officer: Chief Digital & Trans Officer 5000 TOWN CENTER, U, SOUTHFIELD MI 48075
Thomas W Hofmann director FIVE RADNOR CORPORATE CENTER, SUITE 500, RADNOR PA 19087
Chad Winters officer: VP, CAO & Controller 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Annette F Favorite officer: Sr. VP Human Resources Officer 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Cindy Reiss-clark officer: Senior Vice President 530 HERMAN O. WEST DRIVE, EXTON PA 19341-1147
Quintin J Lai officer: VP Corp Development & Strategy 530 HERMAN 0. WEST DRIVE, EXTON PA 19341
Bernard Birkett officer: Sr VP, CFO & Treasurer 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Stephen H Lockhart director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Molly Joseph director 9209 GRAND SUMMIT BLVD, DRIPPING SPRINGS TX 78620
Kimberly Banks Mackay officer: SVP, GC & Corporate Secretary 530 HERMAN O. WEST DRIVE, EXTON PA 19341
George Lloyd Miller officer: Sr. VP, GC & Corp. Sec. 530 HERMAN O. WEST DRIVE, EXTON PA 19341
David A Montecalvo officer: SVP, Glob Ops and Supply Chain 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Robert F Friel director 940 WINTER STREET, WALTHAM MA 02451